BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹74 Cr | ₹81 Cr | ₹-241 Cr | ₹-275 Cr | ₹-338 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹74 Cr |
Mar2023 | ₹81 Cr |
Mar2022 | ₹-241 Cr |
Mar2021 | ₹-275 Cr |
Mar2020 | ₹-338 Cr |
How is Deferred Tax Assets / Liabilities of BIOCON Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹74 Cr | -8.17 | |
Mar2023 | ₹81 Cr | Positive | |
Mar2022 | ₹-241 Cr | Negative | |
Mar2021 | ₹-275 Cr | Negative | |
Mar2020 | ₹-338 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹41,882.9 Cr | -7.5% | -11.2% | 32.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,787.0 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -7.5% |
-11.2% |
32.3% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses